Zheng Meige, Duan Junxiu, He Zhendan, Wang Zhiwei, Mu Shuhua, Zeng Zhiwen, Qu Junle, Wang Dong, Zhang Jian
Key Laboratory of Optoelectronic Devices and Systems of Ministry of Education and Guangdong Province, College of Optoelectronic Engineering, Shenzhen University, Shenzhen, China; School of Medicine, Shenzhen University, Shenzhen, China.
School of Medicine, Shenzhen University, Shenzhen, China.
Cytotherapy. 2017 Aug;19(8):916-926. doi: 10.1016/j.jcyt.2017.04.007. Epub 2017 May 29.
Previously we reported that overexpression of tropomyosin receptor kinase A (TrkA) could improve the survival and Schwann-like cell differentiation of bone marrow stromal stem cells (BMSCs) in nerve grafts for bridging rat sciatic nerve defects. The aim of this study was to investigate how TrkA affects the efficacy of BMSCs transplantation on peripheral nerve regeneration and functional recovery.
Rat BMSCs were infected with recombinant lentiviruses to construct TrkA-overexpressing BMSCs and TrkA-shRNA-expressing BMSCs, which were then seeded in acellular nerve allografts for bridging 10-mm rat sciatic nerve defects.
At 8 weeks post-transplantation, compared with Vector and Control BMSCs-laden groups, TrkA-overexpressing BMSCs-laden group demonstrated obviously improved axon growth, such as significantly higher expression of myelin basic protein and superior results of myelinated fiber density, axon diameter and myelin sheaths thickness. In accordance with this increased nerve regeneration, the animals of TrkA-overexpressing BMSCs-laden group showed significantly better restoration of sciatic nerve function, manifested as greater sciatic function index value and superior electrophysiological parameters including shorter onset latency and higher peak amplitude of compound motor action potentials and faster nerve conduction velocity. However, these beneficial effects could be reversed in TrkA-shRNA-expressing BMSCs-laden group, which showed much fewer and smaller axons with thinner myelin sheaths and correspondingly poor functional recovery.
These results demonstrated that TrkA may regulate the regenerative potential of BMSCs in nerve grafts, and TrkA overexpression can enhance the efficacy of BMSCs on peripheral nerve regeneration and functional recovery, which may help establish novel strategies for repairing peripheral nerve injuries.
此前我们报道过,原肌球蛋白受体激酶A(TrkA)的过表达可提高用于桥接大鼠坐骨神经缺损的神经移植物中骨髓基质干细胞(BMSC)的存活率及向雪旺样细胞的分化。本研究旨在探讨TrkA如何影响BMSC移植对周围神经再生和功能恢复的疗效。
用重组慢病毒感染大鼠BMSC,构建过表达TrkA的BMSC和表达TrkA-shRNA的BMSC,然后将其接种于脱细胞异体神经移植物中,用于桥接10毫米的大鼠坐骨神经缺损。
移植后8周,与载体组和对照BMSC负载组相比,过表达TrkA的BMSC负载组显示轴突生长明显改善,如髓鞘碱性蛋白表达显著更高,髓鞘纤维密度、轴突直径和髓鞘厚度的结果更佳。随着神经再生的增加,过表达TrkA的BMSC负载组的动物坐骨神经功能恢复明显更好,表现为坐骨神经功能指数值更高,电生理参数更优,包括复合运动动作电位的起始潜伏期更短、峰值幅度更高以及神经传导速度更快。然而,这些有益作用在表达TrkA-shRNA的BMSC负载组中可被逆转,该组显示轴突数量更少、更小,髓鞘更薄,相应地功能恢复较差。
这些结果表明,TrkA可能调节神经移植物中BMSC的再生潜能,TrkA过表达可增强BMSC对周围神经再生和功能恢复的疗效,这可能有助于建立修复周围神经损伤的新策略。